‘Progressive ataxia’ in a Charolais steer in New Zealand     

FI Hill  AF Julian  J Roiri 《New Zealand veterinary journal》2013,61(4)

Extract

Signs of progressive central nervous system disease in cattle aged 2 years and older should alert farmers and veterinarians to consider the possibility of bovine spongiform encephalopathy (BSE). Government veterinarians routinely assess all livestock slaughtered in meat plants in New Zealand for signs of any nervous disorder, including abnormalities of behaviour and mental state and abnormalities of posture and gait.  相似文献   

Attempted immunisation of laboratory animals with metabolic antigens ofFasciola hepatica     

R. P. Lehner  M. M. H. Sewell 《Veterinary research communications》1978,2(1):337-340

Six experiments failed to demonstrate resistance to infection withFasciola hepatica in rabbits, rats or mice, following vaccination with metabolic products obtained from these flukes while they were maintainedin vitro. One of these experiments was an attempt to reproduce the earlier work described by Lang (1976). Variations in the parameters in the other experiments included differences in the maturity of the flukes, the methods used to maintain them and in the preparation of the vaccine. The strain of rats used is known to be capable of developing resistance toF. hepatica.  相似文献   

Intranuclear inclusion disease of pigeons     

N D Lehner  B C Bullock  T B Clarkson 《Journal of the American Veterinary Medical Association》1967,151(7):939-941

  相似文献   

Diclazuril in the horse: its identification and detection and preliminary pharmacokinetics   总被引：1，自引：0，他引：1  

Dirikolu L  Lehner F  Nattrass C  Bentz BG  Woods WE  Carter WG  Karpiesiuk W  Jacobs J  Boyles J  Harkins JD  Granstrom DE  Tobin T 《Journal of veterinary pharmacology and therapeutics》1999,22(6):374-379

Diclazuril (4-chlorophenyl [2,6-dichloro-4-(4,5-dihydro-3H-3,5-dioxo-1,2,4-triazin-2-yl)pheny l] acetonitrile), is a benzeneacetonitrile antiprotozoal agent (Janssen Research Compound R 64433) marketed as Clinacox . Diclazuril may have clinical application in the treatment of Equine Protozoal Myeloencephalitis (EPM). To evaluate its bioavailability and preliminary pharmacokinetics in the horse we developed a sensitive quantitative high-pressure liquid chromatography (HPLC) method for diclazuril in equine biological fluids. MS/MS analysis of diclazuril in our HPLC solvent yielded mass spectral data consistent with the presence of diclazuril. After a single oral dose of diclazuril at 2.5 g/450 kg (as 500 g Clinacox), plasma samples from four horses showed good plasma concentrations of diclazuril which peaked at 1.077 +/- 0.174 microg/mL (mean +/- SEM) with an apparent plasma half-life of about 43 h. When this dose of Clinacox was administered daily for 21 days to two horses, mean steady state plasma concentrations of 7-9 microg/mL were attained. Steady-state levels in the CSF ranged between 100 and 250 ng/mL. There was no detectable parent diclazuril in the urine samples of dosed horses by HPLC or by routine postrace thin layer chromatography (TLC). These results show that diclazuril is absorbed after oral administration and attains steady-state concentrations in plasma and CSF. The steady state concentrations attained in CSF are more than sufficient to interfere with Sarcocystis neurona, whose proliferation is reportedly 95% inhibited by concentrations of diclazuril as low as 1 ng/mL. These results are therefore entirely consistent with and support the reported clinical efficacy of diclazuril in the treatment of clinical cases of EPM.  相似文献   

Yellow sigatoka epidemics caused by a panmictic population of Mycosphaerella musicola in Brazil          下载免费PDF全文

L. I. S. Gomes  G. W. Douhan  M. S. Lehner  L. B. J. Bibiano  E. S. G. Mizubuti 《Plant pathology》2018,67(2):295-302

The genetic structure of Mycosphaerella musicola has never been investigated in Brazil to address epidemiologically related questions associated with yellow sigatoka. A total of 223 single‐conidium isolates from four regions (North, South, Zona da Mata and Triângulo Mineiro) of Minas Gerais State, Brazil, were used to assess the population genetic structure of M. musicola. Isolates were characterized regarding the frequency of the MAT1‐1‐1 or MAT1‐2‐1 idiomorphs and polymorphism at nine microsatellite loci. The mating‐type ratio in three of the four subpopulations was c. 1:1. A total of 87 alleles and 216 multilocus genotypes were identified. The overall population was in linkage equilibrium. Most (93.9%) genetic variation was detected within the subpopulations and there was weak differentiation between them. In total, eight genetic groups were detected and isolates of seven groups were present in all regions. The population of M. musicola in Minas Gerais seems to have high evolutionary potential: it is panmictic and both sexual reproduction and gene flow affect genetic variability. Strategies to avoid fungicide resistance should be enforced and breeding programmes need to consider quantitative resistance in the banana cultivars.  相似文献   

The detection and biotransformation of guanabenz in horses: a preliminary report     

Harkins JD  Dirikolu L  Lehner AF  Hughes C  Schroedter D  Mayer B  Bratton C  Fisher MV  Tobin T 《Veterinary therapeutics : research in applied veterinary medicine》2003,4(2):197-209

Guanabenz (2,6-dichlorobenzylidene-amino-guanidine) is a centrally acting antihypertensive drug whose mechanism of action is via alpha2 adrenoceptors or, more likely, imidazoline receptors. Guanabenz is marketed as an antihypertensive agent in human medicine (Wytensin tablets, Wyeth Pharmaceuticals). Guanabenz has reportedly been administered to racing horses and is classified by the Association of Racing Commissioners International as a class 3 foreign substance. As such, its identification in a postrace sample may result in significant sanctions against the trainer of the horse. The present study examined liquid chromatographic/tandem quadrupole mass spectrometric (LC-MS/MS) detection of guanabenz in serum samples from horses treated with guanabenz by rapid i.v. injection at 0.04 and 0.2 mg/kg. Using a method adapted from previous work with clenbuterol, the parent compound was detected in serum with an apparent limit of detection of approximately 0.03 ng/ml and the limit of quantitation was 0.2 ng/ml. Serum concentrations of guanabenz peaked at approximately 100 ng/ml after the 0.2 mg/kg dose, and the parent compound was detected for up to 8 hours after the 0.04 mg/kg dose. Urine samples tested after administration of guanabenz at these dosages yielded evidence of at least one glucuronide metabolite, with the glucuronide ring apparently linked to a ring hydroxyl group or a guanidinium hydroxylamine. The LC-MS/MS results presented here form the basis of a confirmatory test for guanabenz in racing horses.  相似文献   

Compression of Ice to 210 Gigapascals: Infrared Evidence for a Symmetric Hydrogen-Bonded Phase     

AF Goncharov  VV Struzhkin  MS Somayazulu  RJ Hemley  HK Mao 《Science (New York, N.Y.)》1996,273(5272):218-220

Protonated and deuterated ices (H2O and D2O) compressed to a maximum pressure of 210 gigapascals at 85 to 300 kelvin exhibit a phase transition at 60 gigapascals in H2O ice (70 gigapascals in D2O ice) on the basis of their infrared reflectance spectra determined with synchrotron radiation. The transition is characterized by soft-mode behavior of the nu3 O-H or O-D stretch below the transition, followed by a hardening (positive pressure shift) above it. This behavior is interpreted as the transformation of ice phase VII to a structure with symmetric hydrogen bonds. The spectroscopic features of the phase persisted to the maximum pressures (210 gigapascals) of the measurements, although changes in vibrational mode coupling were observed at 150 to 160 gigapascals.  相似文献   

A national programme for mastitis control in Australia: Countdown Downunder     

PB Brightling  RD Dyson  AF Hope  J Penry 《Irish veterinary journal》2009,62(Z4):S52

In 1998, Countdown Downunder, Australia's national mastitis and cell count control programme, was created. With funding from the country's leading dairy organisation, Dairy Australia, this programme was originally intended to run for three years but is now in its tenth year. As it was the first time Australia had attempted a national approach to mastitis control on the farm, the first three years of the programme were largely concerned with the development of resources to be used by farmers and service providers. The second three years were devoted to training with both groups. Since that time, Countdown Downunder has entered into a second resource development phase. The goal of the programme was to achieve a reduction in the bulk milk somatic cell count from the Australian dairy herd. To achieve this, the programme had to develop resources with clear and consistent messages around mastitis and somatic cell count control on farms. It was determined that progress toward the goals would be made more rapidly if service providers were trained in the use of these resources prior to farmers. This paper reviews the Countdown Downunder programme from 1998 to 2007.  相似文献   

Identification of hydroxyropivacaine glucuronide in equine urine by ESI+/MS/MS.          下载免费PDF全文

J D Harkins  W Karpiesiuk  T Tobin  L Dirikolu    A F Lehner 《Canadian journal of veterinary research》2000,64(3):178-183

Ropivacaine is a local anesthetic that has a high potential for abuse in racing horses. It can be recovered from urine collected after administration as a hydroxylated metabolite following beta-glucuronidase treatment of the urine. Based on these findings, it has been inferred that ropivacaine is present in equine urine as a glucuronide metabolite; however, these metabolites have never been directly identified. Using ESI+/MS/MS, the presence of a [M+H]+ molecular ion of m/z 467 was demonstrated in urine corresponding to the calculated mass of a hydroxyropivacaine glucuronide +1. The abundance of this ion diminished after glucuronidase treatment with concomitant appearance of a m/z 291 peak, which is consistent with its hydrolysis to hydroxyropivacaine. In further work, the m/z 467 material was fragmented in the MS/MS system, yielding fragments interpretable as hydroxyropivacaine glucuronide. These data are consistent with the presence of a hydroxyropivacaine glucuronide in equine urine and constitute the first direct demonstration of a specific glucuronide metabolite in equine urine.  相似文献